RNA NASDAQ
Atrium Therapeutics, Inc.
1W: -5.4%
1M: -44.2%
3M: -39.7%
YTD: -89.1%
1Y: -82.0%
3Y: +22.9%
5Y: -67.7%
$7.84
-0.30 (-3.69%)
Weekly Expected Move ±11.5%
$6
$7
$8
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$36M
Revenue
+235.3% YoY
$-259M
Net Income
+43.1% YoY
$-217M
Free Cash Flow
+56.8% YoY
88.6%
Gross Margin
-752.9%
Op. Margin
-672.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-36.9%
ROA-31.4%
ROIC455.9%
Valuation
P/E-2.0
P/B0.6
EV/EBITDA0.1
Leverage
Debt/Equity0.01
Current Ratio8.73
Interest Cov.0.0x
Quality Scores
Piotroski F5/9
Altman Z0.14
Beneish M-27.30